China Kidney Patient Trials Network

Recruiting

• Conditions: Kidney Diseases

• Registration Number: NCT05036850
• Lead Sponsor: George (Beijing) Clinical Research Co. Ltd.

Brief Summary

This is a prospective multi-centre, observational cohort study of incident and prevalent patients diagnosed with a kidney disease in China.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-08-27
• Study First Submitted QC: 2021-09-07
• Study First Posted: 2021-09-08
• Study Start: 2021-09-27
• Status Verified: 2023-03
• Last Update Submitted: 2023-03-03
• Last Update Posted: 2023-03-06
• Primary Completion: 2026-09-15
• Study Completion: 2031-02-28

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

1. Documented diagnosis of primary kidney disease
2. Regular visits (at least 6 monthly) with a physician at a participating site
3. eGFR > 15 ml/min/1.73 m2
4. ≥ 2 years of age
5. Willing and able to sign informed consent
6. Willing to be approached about participation in interventional research studies

Exclusion Criteria

• 1. Life-expectancy of less than 6 months

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Albuminuria	Collected six monthly, up to 5 years	Routine results
eGFR (estimated Glomerular Filtration Rate)	Collected six monthly, up to 5 years	Routine results

Trial Locations

Locations (1)

George Clinical (Beijing); 🇨🇳 Beijing, Beijing, China